Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

3D camera could sharpen colonoscopy accuracy

NCT ID NCT06922877

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 11, 2026 · Updated 3 times

Summary

This completed trial tested whether a 3D imaging device helps doctors more accurately classify colon polyps and adenomas during colonoscopy compared to standard 2D imaging. 460 adults with colorectal polyps were randomly assigned to either 3D or 2D imaging before polyp removal. The goal was to see if 3D improves diagnostic accuracy, using pathology as the gold standard. Participants were followed for 30 days to track any side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
3-dimensional imaging device
What this could lead to
If successful, 3D imaging could help doctors more accurately identify polyps during colonoscopy, potentially reducing the need for repeat procedures.
What could go wrong
This is a single-center study with 460 participants, so results may not apply broadly. The technology may not significantly improve accuracy over standard 2D imaging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

458 people

The number who actually took part.

Started

May 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥18 years; * Underwent non-3D white-light colonoscopy with at least one colorectal polyp identified; * Endoscopically estimated polyp size \<10 mm; * No indication for endoscopic submucosal dissection (ESD); * Scheduled for inpatient polypectomy; * Provided written informed consent. Exclusion Criteria: * History of any polypectomy; * History of colorectal surgery; * Inflammatory bowel disease (Crohn's disease or ulcerative colitis); * Hereditary polyposis syndromes; * Concurrent colorectal cancer; * Contraindications to colonoscopy (e.g., severe cardiopulmonary insufficiency); * Coagulopathy or failure to discontinue antithrombotic agents; * Inability to cooperate with procedures; * Pregnancy or lactation; * Refusal to participate or inability to give informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal adenomas are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Xijing Hospital of Digestive Disease

    Xi'an, Shaanxi, 710032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.